Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Accounts Payables (2023 - 2026)

Camp4 Therapeutics' Accounts Payables history spans 3 years, with the latest figure at $182000.0 for Q4 2025.

  • On a quarterly basis, Accounts Payables fell 84.96% to $182000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $182000.0, a 84.96% decrease, with the full-year FY2025 number at $182000.0, down 84.96% from a year prior.
  • Accounts Payables hit $182000.0 in Q4 2025 for Camp4 Therapeutics, down from $585000.0 in the prior quarter.
  • Over the last five years, Accounts Payables for CAMP hit a ceiling of $3.9 million in Q3 2024 and a floor of $182000.0 in Q4 2025.
  • Historically, Accounts Payables has averaged $1.4 million across 3 years, with a median of $1.2 million in 2025.
  • Biggest five-year swings in Accounts Payables: rose 16.12% in 2024 and later tumbled 84.96% in 2025.
  • Tracing CAMP's Accounts Payables over 3 years: stood at $1.0 million in 2023, then grew by 16.12% to $1.2 million in 2024, then tumbled by 84.96% to $182000.0 in 2025.
  • Business Quant data shows Accounts Payables for CAMP at $182000.0 in Q4 2025, $585000.0 in Q3 2025, and $1.2 million in Q2 2025.